Terms: = Cervical cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
21 results:
1. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
Zhang X; Wang M; Zhang Y; Yang J; Duan W
Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
[TBL] [Abstract] [Full Text] [Related]
2. ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy.
Javed S; Sood S; Rai B; Bhattacharyya S; Bagga R; Srinivasan R
Indian J Med Res; 2021 Aug; 154(2):367-374. PubMed ID: 35295009
[TBL] [Abstract] [Full Text] [Related]
3. MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.
Mei J; Zhu C; Pan L; Li M
Bioengineered; 2022 Jan; 13(1):61-70. PubMed ID: 34939526
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA AFAP1-AS1/miR-27b-3p/VEGF-C axis modulates stemness characteristics in cervical cancer cells.
Xia M; Duan LJ; Lu BN; Pang YZ; Pang ZR
Chin Med J (Engl); 2021 Jul; 134(17):2091-2101. PubMed ID: 34334630
[TBL] [Abstract] [Full Text] [Related]
5. Apigenin as an anticancer agent.
Imran M; Aslam Gondal T; Atif M; Shahbaz M; Batool Qaisarani T; Hanif Mughal M; Salehi B; Martorell M; Sharifi-Rad J
Phytother Res; 2020 Aug; 34(8):1812-1828. PubMed ID: 32059077
[TBL] [Abstract] [Full Text] [Related]
6. α-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis.
Chien HJ; Ying TH; Hsieh SC; Lin CL; Yu YL; Kao SH; Hsieh YH
J Cell Physiol; 2020 Jul; 235(7-8):5590-5601. PubMed ID: 31960449
[TBL] [Abstract] [Full Text] [Related]
7. Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
Nayak A; Das S; Nayak D; Sethy C; Narayan S; Kundu CN
Cell Oncol (Dordr); 2019 Apr; 42(2):157-171. PubMed ID: 30603978
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
[TBL] [Abstract] [Full Text] [Related]
9. Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the oct4-miR-18a pathway in cervical cancer.
Dong P; Xiong Y; Yu J; Chen L; Tao T; Yi S; Hanley SJB; Yue J; Watari H; Sakuragi N
Oncogene; 2018 Sep; 37(39):5257-5268. PubMed ID: 29855617
[TBL] [Abstract] [Full Text] [Related]
10. CD44+/CD24+ cervical cancer cells resist radiotherapy and exhibit properties of cancer stem cells.
Liu H; Wang YJ; Bian L; Fang ZH; Zhang QY; Cheng JX
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1745-54. PubMed ID: 27212166
[TBL] [Abstract] [Full Text] [Related]
11. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human cervical Carcinoma Stem Cells.
Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
[TBL] [Abstract] [Full Text] [Related]
12. Imiquimod treatment effectively reduces the percentage of viable cells in a cervical carcinoma cell line but does not affect the expression of HLA-G or OCT-4.
Stefanidis K; Patta J; Pergialiotis V; Stefanidi D; Loutradis D
J Stem Cells; 2015; 10(4):217-23. PubMed ID: 27144826
[TBL] [Abstract] [Full Text] [Related]
13. [A case of primary unknown cancer difficult to distinguish from lung cancer].
Tanaka Y; Tago K; Narabayashi T; Sasaki Y; Iwahashi E; Hibino C; Iwasaki T; Watanabe T; Kasugai T; Kohama J; Ohno K
Gan To Kagaku Ryoho; 2014 May; 41(5):627-31. PubMed ID: 24917010
[TBL] [Abstract] [Full Text] [Related]
14. High Expression of SOX2 and oct4 Indicates Radiation Resistance and an Independent Negative Prognosis in cervical Squamous Cell Carcinoma.
Shen L; Huang X; Xie X; Su J; Yuan J; Chen X
J Histochem Cytochem; 2014 Jul; 62(7):499-509. PubMed ID: 24710660
[TBL] [Abstract] [Full Text] [Related]
15. Clinical significance of the stem cell gene Oct-4 in cervical cancer.
Yang Y; Wang Y; Yin C; Li X
Tumour Biol; 2014 Jun; 35(6):5339-45. PubMed ID: 24532469
[TBL] [Abstract] [Full Text] [Related]
16. Cisplatin induces resistance by triggering differentiation of testicular embryonal carcinoma cells.
Abada PB; Howell SB
PLoS One; 2014; 9(1):e87444. PubMed ID: 24475288
[TBL] [Abstract] [Full Text] [Related]
17. High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.
Liu SY; Zheng PS
Oncotarget; 2013 Dec; 4(12):2462-75. PubMed ID: 24318570
[TBL] [Abstract] [Full Text] [Related]
18. Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction.
Wang L; Guo H; Yang L; Dong L; Lin C; Zhang J; Lin P; Wang X
Mol Cell Biochem; 2013 Jul; 379(1-2):7-18. PubMed ID: 23543150
[TBL] [Abstract] [Full Text] [Related]
19. HPV16 activates the promoter of oct4 gene by sequestering HDAC1 from repressor complex to target it to proteasomal degradation.
Liu D; Zhou P; Zhang L; Zheng Y; He F
Med Hypotheses; 2012 Oct; 79(4):531-4. PubMed ID: 22867868
[TBL] [Abstract] [Full Text] [Related]
20. HDAC1/DNMT3A-containing complex is associated with suppression of oct4 in cervical cancer cells.
Liu D; Zhou P; Zhang L; Gong W; Huang G; Zheng Y; He F
Biochemistry (Mosc); 2012 Aug; 77(8):934-40. PubMed ID: 22860916
[TBL] [Abstract] [Full Text] [Related]
[Next]
